BioSpace News Archive

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its first quarter 2023 financial results after market close on Tuesday, May 2, 2023.

OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in five upcoming investor conferences in May.

Cardiac Dimensions today announced that its Carillon Mitral Contour System ® has received certification under Regulation (EU) 2017/745 (“MDR”).

Halberd Corporation. The first quarter 2023 continued this extraordinarily groundbreaking path, packed with new accomplishments.

MiNA Therapeutics today announced a multi-target research collaboration and option licensing agreement with BioMarin Pharmaceutical Inc.

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that it plans to release first quarter 2023 financial and operating results prior to market open on Tuesday, May 9th, 2023.

Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced it will release its first quarter 2023 financial and operating results on Tuesday, May 9, 2023, following the close of trading.

Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced the initiation of the ReMMi-D, Reduction in Monthly Migraine Days study, a fully remote and decentralized pivotal trial designed to investigate the efficacy and safety of prescription digital therapeutics in reducing the number of monthly migraine days for adults diagnosed with episodic migraine.

Gigantor Technologies, Inc. is already disrupting the market with artificial intelligence (AI) acceleration solutions.

NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) (“NLS” or the “Company”) today announced it will present new and compelling preclinical data on four of its pipeline compounds at the annual meeting of the American Society of Clinical Psychopharmacology (ASCP), which is being held from May 30 to June 2, 2023, in Miami, Florida.